Compounds > agreal
Page last updated: 2024-08-23

agreal and Hot Flashes

agreal has been researched along with Hot Flashes in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertazzo, A; Carretti, N; Comai, S; Florio, P; Petraglia, F; Reis, FM1
Carranza-Lira, S1
Butterweck, V; Christoffel, V; Löhning, A; Spengler, B; Winterhoff, H1
Fitzpatrick, LA1
Cianci, A; De Leo, V; Farina, M; La Marca, A; Morgante, G; Petraglia, F1
De Leo, V; Delia, A; Faldini, E; Morgante, G; Musacchio, MC; Petraglia, F1
Carranza-Lira, S; Cortés-Fuentes, E1

Reviews

3 review(s) available for agreal and Hot Flashes

ArticleYear
Actual status of veralipride use.
    Clinical interventions in aging, 2010, Sep-07, Volume: 5

    Topics: Antipsychotic Agents; Female; Hot Flashes; Humans; Menopause; Sulpiride

2010
Alternatives to estrogen.
    The Medical clinics of North America, 2003, Volume: 87, Issue:5

    Topics: Acetates; Acupuncture Therapy; Adrenergic alpha-Agonists; Amines; Antidepressive Agents, Second-Generation; Antioxidants; Behavior Therapy; Belladonna Alkaloids; Cimicifuga; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Combinations; Ergotamines; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Isoflavones; Menopause; Methysergide; Phenobarbital; Phytoestrogens; Plant Preparations; Selective Serotonin Reuptake Inhibitors; Sulpiride; United States; Vitamin E; Women's Health

2003
The safety of veralipride.
    Expert opinion on drug safety, 2006, Volume: 5, Issue:5

    Topics: Adult; Aged; Basal Ganglia Diseases; Dopamine D2 Receptor Antagonists; Estrogens; Female; Half-Life; Hot Flashes; Humans; Middle Aged; Parkinsonian Disorders; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Sulpiride

2006

Trials

3 trial(s) available for agreal and Hot Flashes

ArticleYear
Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
    Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:2

    Topics: Analysis of Variance; Chromatography, High Pressure Liquid; Dopamine Antagonists; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Serotonin; Sulpiride; Tryptophan

2010
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:4

    Topics: Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Female; Hot Flashes; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prolactin; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sulpiride; Treatment Outcome

2004
Modification of vasomotor symptoms after various treatment modalities in the postmenopause.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2001, Volume: 73, Issue:2

    Topics: Clonidine; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Propranolol; Sulpiride; Treatment Outcome; Vasodilator Agents

2001

Other Studies

1 other study(ies) available for agreal and Hot Flashes

ArticleYear
Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.
    Maturitas, 2003, Mar-14, Volume: 44 Suppl 1

    Topics: Animals; Behavior, Animal; Body Temperature; Cimicifuga; Depression; Dose-Response Relationship, Drug; Estrogens; Female; Hot Flashes; Imipramine; Menopause; Mice; Models, Animal; Ovariectomy; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Sulpiride

2003